Gotham Asset Management, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$213,710
-62.1%
5,993
-56.9%
0.01%
-68.8%
Q4 2022$563,378
-30.7%
13,890
-43.5%
0.02%
-33.3%
Q3 2022$813,000
-6.4%
24,596
-0.4%
0.02%
-14.3%
Q2 2022$869,000
+53.3%
24,687
+100.3%
0.03%
+55.6%
Q1 2022$567,000
-31.1%
12,322
-0.7%
0.02%
-33.3%
Q4 2021$823,000
+6.2%
12,4110.0%0.03%
-12.9%
Q3 2021$775,000
-24.7%
12,411
-0.1%
0.03%
-29.5%
Q2 2021$1,029,000
+24.9%
12,4260.0%0.04%
+18.9%
Q1 2021$824,000
-40.1%
12,426
-30.6%
0.04%
-17.8%
Q4 2020$1,375,000
+5.4%
17,915
-40.9%
0.04%
+7.1%
Q3 2020$1,305,000
-51.2%
30,317
-51.0%
0.04%
-47.5%
Q2 2020$2,673,000
-13.6%
61,897
-42.4%
0.08%
-7.0%
Q1 2020$3,093,000
-64.8%
107,524
-22.4%
0.09%
-46.6%
Q4 2019$8,786,000
+16.2%
138,511
-48.4%
0.16%
+20.1%
Q3 2019$7,562,000
+210.0%
268,348
+191.6%
0.13%
+243.6%
Q2 2019$2,439,000
+256.1%
92,031
+146.7%
0.04%
+290.0%
Q1 2019$685,00037,3030.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders